Effect of Bleomycin plus cryotherapy in treatment of keloid

Comparison of the efficacy of intralesional Bleomycin plus cryotherapy versus intralesional Triamcinolone plus cryotherapy in the treatment of keloid

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200108046060N1

Enrollment

Registered

2020-01-18

Start date

2020-01-10

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid.

Interventions

Intervention 1: Intervention group: Intralesional Bleomycin plus cryotherapy. Intervention 2: Control group: Intralesional Triamcinolone plus cryotherapy.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Skin type 2 to 5 based on Fitzpatrick Having 1 to 3 keloids 1 to 5 cm in diameter from neck to bottom

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Hypersensitivity to Bleomycin Pregnancy Lactation

Design outcomes

Primary

Measure	Time frame
Vancouver Scar Scale. Timepoint: At baseline and 3 months after onset. Method of measurement: Vancouver Scar Scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForghanian Ali

Shahid Beheshti University of Medical Sciences

ali_forghanian8611@sbmu.ac.ir+98 21 5541 9005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026